Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma
Clinical trial NCT06435273 · COMPLETED
Trial details
- NCT number
- NCT06435273
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-05
- Primary completion
- 2025-10-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.